Glycopyrrolate Solution
Product Images NDC 71656-061

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71656-061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Saptalis Pharmaceuticals, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Container Label)

Label for glycopyrrolate oral solution 1 mg/5 mL (0.2 mg/mL) in a 16 fl. oz. (473 mL) bottle. The label includes dosage information, storage instructions, and states it is for oral use only and prescription use. Distributed by Saptalis Pharmaceuticals, LLC.*

FDA Label Image

Image Description (Figure1)

A line graph comparing mean mTSS scores over time between glycopyrrolate and placebo groups. The x-axis represents time points from baseline to week 8, and the y-axis shows mean mTSS scores, with data points for weeks 2, 4, 6, and 8. Glycopyrrolate shows a decreasing trend in scores compared to placebo, with error bars displayed for each data point.*

FDA Label Image

Image Description (Structure)

Chemical structure diagram of glycopyrrolate, illustrating its molecular arrangement including the cyclopentyl, phenyl, and quaternary ammonium groups with a bromide counter ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.